These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


94 related items for PubMed ID: 16860294

  • 1. Internal mammary artery smooth muscle cells resist migration and possess high antioxidant capacity.
    Mahadevan VS, Campbell M, McKeown PP, Bayraktutan U.
    Cardiovasc Res; 2006 Oct 01; 72(1):60-8. PubMed ID: 16860294
    [Abstract] [Full Text] [Related]

  • 2. Different migration of vascular smooth muscle cells from human coronary artery bypass vessels. Role of Rho/ROCK pathway.
    Weiss S, Frischknecht K, Greutert H, Payeli S, Steffel J, Lüscher TF, Carrel TP, Tanner FC.
    J Vasc Res; 2007 Oct 01; 44(2):149-56. PubMed ID: 17264516
    [Abstract] [Full Text] [Related]

  • 3. Tissue factor induction by aggregated LDL depends on LDL receptor-related protein expression (LRP1) and Rho A translocation in human vascular smooth muscle cells.
    Camino-López S, Llorente-Cortés V, Sendra J, Badimon L.
    Cardiovasc Res; 2007 Jan 01; 73(1):208-16. PubMed ID: 17141748
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin II increases the expression of lectin-like oxidized low-density lipoprotein receptor-1 in human vascular smooth muscle cells via a lipoxygenase-dependent pathway.
    Limor R, Kaplan M, Sawamura T, Sharon O, Keidar S, Weisinger G, Knoll E, Naidich M, Stern N.
    Am J Hypertens; 2005 Mar 01; 18(3):299-307. PubMed ID: 15797645
    [Abstract] [Full Text] [Related]

  • 5. Antioxidant vitamins C and E ameliorate hyperglycaemia-induced oxidative stress in coronary endothelial cells.
    Ulker S, McMaster D, McKeown PP, Bayraktutan U.
    Diabetes Obes Metab; 2004 Nov 01; 6(6):442-51. PubMed ID: 15479220
    [Abstract] [Full Text] [Related]

  • 6. Differential mechanisms of angiotensin II and PDGF-BB on migration and proliferation of coronary artery smooth muscle cells.
    Allen CL, Bayraktutan U.
    J Mol Cell Cardiol; 2008 Aug 01; 45(2):198-208. PubMed ID: 18573259
    [Abstract] [Full Text] [Related]

  • 7. Effects of oxidized low density lipoprotein on the growth of human artery smooth muscle cells.
    Zhao GF, Seng JJ, Zhang H, She MP.
    Chin Med J (Engl); 2005 Dec 05; 118(23):1973-8. PubMed ID: 16336833
    [Abstract] [Full Text] [Related]

  • 8. Pioglitazone inhibits homocysteine-induced migration of vascular smooth muscle cells through a peroxisome proliferator-activated receptor gamma-independent mechanism.
    Li L, Gao PJ, Xi R, Wu CF, Zhu DL, Yan J, Lu GP.
    Clin Exp Pharmacol Physiol; 2008 Dec 05; 35(12):1471-6. PubMed ID: 18759864
    [Abstract] [Full Text] [Related]

  • 9. Low-density lipoproteins impair migration of human coronary vascular smooth muscle cells and induce changes in the proteomic profile of myosin light chain.
    Padró T, Peña E, García-Arguinzonis M, Llorente-Cortes V, Badimon L.
    Cardiovasc Res; 2008 Jan 05; 77(1):211-20. PubMed ID: 18006454
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic effect of magnesium lithospermate B on neointimal formation after balloon-induced vascular injury.
    Hur KY, Seo HJ, Kang ES, Kim SH, Song S, Kim EH, Lim S, Choi C, Heo JH, Hwang KC, Ahn CW, Cha BS, Jung M, Lee HC.
    Eur J Pharmacol; 2008 May 31; 586(1-3):226-33. PubMed ID: 18387604
    [Abstract] [Full Text] [Related]

  • 11. The role of G proteins in thromospondin-1-induced vascular smooth muscle cell migration.
    Fuse S, Esemuede N, Yamaguchi M, Maier KG, Nesselroth SM, Sumpio BE, Gahtan V.
    Surgery; 2008 Jul 31; 144(1):86-92. PubMed ID: 18571589
    [Abstract] [Full Text] [Related]

  • 12. Human-derived vascular smooth muscle cells produce angiotensin II by changing to the synthetic phenotype.
    Hu WY, Fukuda N, Ikeda Y, Suzuki R, Tahira Y, Takagi H, Matsumoto K, Kanmatsuse K, Mugishima H.
    J Cell Physiol; 2003 Aug 31; 196(2):284-92. PubMed ID: 12811821
    [Abstract] [Full Text] [Related]

  • 13. Human urotensin-II potentiates the mitogenic effect of mildly oxidized low-density lipoprotein on vascular smooth muscle cells: comparison with other vasoactive agents and hydrogen peroxide.
    Watanabe T, Takahashi K, Kanome T, Hongo S, Miyazaki A, Koba S, Katagiri T, Pakara R, Benedict CR.
    Hypertens Res; 2006 Oct 31; 29(10):821-31. PubMed ID: 17283870
    [Abstract] [Full Text] [Related]

  • 14. Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence.
    Min LJ, Mogi M, Iwanami J, Li JM, Sakata A, Fujita T, Tsukuda K, Iwai M, Horiuchi M.
    Cardiovasc Res; 2007 Dec 01; 76(3):506-16. PubMed ID: 17706954
    [Abstract] [Full Text] [Related]

  • 15. Prothrombotic gene expression profile in vascular smooth muscle cells of human saphenous vein, but not internal mammary artery.
    Payeli SK, Latini R, Gebhard C, Patrignani A, Wagner U, Lüscher TF, Tanner FC.
    Arterioscler Thromb Vasc Biol; 2008 Apr 01; 28(4):705-10. PubMed ID: 18258816
    [Abstract] [Full Text] [Related]

  • 16. Activation of natriuretic peptide receptor-C attenuates the enhanced oxidative stress in vascular smooth muscle cells from spontaneously hypertensive rats: implication of Gialpha protein.
    Saha S, Li Y, Lappas G, Anand-Srivastava MB.
    J Mol Cell Cardiol; 2008 Feb 01; 44(2):336-44. PubMed ID: 18162186
    [Abstract] [Full Text] [Related]

  • 17. Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways.
    Montezano AC, Callera GE, Yogi A, He Y, Tostes RC, He G, Schiffrin EL, Touyz RM.
    Arterioscler Thromb Vasc Biol; 2008 Aug 01; 28(8):1511-8. PubMed ID: 18467645
    [Abstract] [Full Text] [Related]

  • 18. Statins and nitric oxide donors affect thrombospondin 1-induced chemotaxis.
    Seymour K, Stein J, Han X, Maier KG, Gahtan V.
    Vasc Endovascular Surg; 2014 Aug 01; 48(7-8):470-5. PubMed ID: 25361959
    [Abstract] [Full Text] [Related]

  • 19. The effect of six different statins on the proliferation, migration, and invasion of human smooth muscle cells.
    Corpataux JM, Naik J, Porter KE, London NJ.
    J Surg Res; 2005 Nov 01; 129(1):52-6. PubMed ID: 16087194
    [Abstract] [Full Text] [Related]

  • 20. Possible involvement of Rho-kinase in aldosterone-induced vascular smooth muscle cell remodeling.
    Miyata K, Hitomi H, Guo P, Zhang GX, Kimura S, Kiyomoto H, Hosomi N, Kagami S, Kohno M, Nishiyama A.
    Hypertens Res; 2008 Jul 01; 31(7):1407-13. PubMed ID: 18957812
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.